XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
Hangzhou Gaoxin Materials Technology
300478
Beijing Philisense Technology
300287
CN Stock MarketDetailed Quotes
688321 Shenzhen Chipscreen Biosciences
- 18.40
- +0.46+2.56%
Market Closed Feb 14 15:00 CST
7.50BMarket Cap-106.98P/E (TTM)
18.57High17.89Low48.62KlotVolume17.95Open17.94Pre Close89.33MTurnover1.19%Turnover Ratio84.40P/E (Static)407.80MShares25.9952wk High4.94P/B7.50BFloat Cap15.1552wk Low21.53Limit Up407.80MShs Float125.00Historical High14.35Limit Down3.79%Amplitude12.47Historical Low--Dividend TTM18.37Avg Price20.60KlotAsk--Div YieldTTM100Lot Size25.66KlotBid
Shenzhen Chipscreen Biosciences News
Microchip Biotech: Legal Opinion of Shanghai Tongli Law Firm on Shenzhen Microchip Biotechnology Co., Ltd. receiving the “Notice of Acceptance of the Request for Invalidation”
Microchip Biotech: Notice of Voluntary Disclosure of Sidabendamide Obtaining Approval Letter for Drug Clinical Trials
Microchip Biotech: Notice on receipt of the “Notice of Acceptance of the Request for Invalidation”
Notice on receipt of the “Notice of Acceptance of the Request for Invalidity Declaration”
Notice of voluntary disclosure of sidabendamide obtaining approval for drug clinical trials
Legal opinion of Shanghai Tongli Law Firm on the receipt by Shenzhen Microchip Biotechnology Co., Ltd. of the “Notice of Acceptance of the Request for Invalidation”
An indicative announcement that some shareholders no longer form a concerted action relationship and changes in rights
2024 Annual Results Forecast Announcement
Shenzhen Microchip Biotechnology Co., Ltd. Simplified Equity Change Report
Microchip Biology: Shenzhen Microchip Biotechnology Co., Ltd. Information Disclosure Management System (January 2025)
Microchip Biotech: Notice on receipt of the “Notice of Acceptance of the Request for Invalidation”
Microchip Biotech: SDIC Securities Co., Ltd.\'s inspection opinion on the extension of some fund-raising investment projects of Shenzhen Microchip Biotech Co., Ltd.
Microchip Biology: Shenzhen Microchip Biotechnology Co., Ltd. Internal Reporting System for Important Matters (January 2025)
Microchip Biotech: Announcement on Appointment of Co-General Manager
Microchip Biotech: Legal Opinion of Shanghai Tongli Law Firm on Shenzhen Microchip Biotechnology Co., Ltd. receiving the “Notice of Acceptance of the Request for Invalidation”
Microchip Biotech: Announcement of Resolutions of the 9th Meeting of the 3rd Board of Directors
Microchip Biotech: Announcement of Resolutions of the 7th Meeting of the 3rd Board of Supervisors
Microchip Biotech: Resolutions of the 1st Meeting of the 3rd Special Meeting of Independent Directors of the Board of Directors in 2025
Microchip Biotech: Announcement on the extension of some fund-raising investment projects
Microchip Biotech: Announcement on the estimated amount of daily related transactions in 2025
